In the SS context, reduced immunohistochemical detection of IGF1R has been previously shown in an animal model of experimental autoimmune sialadenitis [26] as well as in salivary gland tissues from SS patients [27], along with increased IGF1 expression [28], compared to controls. Here, IGF1 is linked to synovial sarcoma.